Sign Out
Regular consultation with a healthcare provider is recommended while using Medroxyprogesterone Acetate (DEPOTRUST). Inform the healthcare provider if the patient is suffering from the following conditions: cardiac or renal impairment; epilepsy; asthma; past ectopic pregnancy; history of depression; diabetes mellitus; hypertension; migraine; thromboembolism; other conditions which may be aggravated by fluid retention.
Breastfeeding women should wait six weeks after giving birth before the administration of Medroxyprogesterone Acetate (DEPOTRUST).
Continue with Google